Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype

Pullinger, Clive R.; Eng, Celeste; Salen, Gerald; Shefer, Sarah; Batta, Ashok K.; Erickson, Sandra K.; Verhagen, Andrea; Rivera, Christopher R.; Mulvihill, Sean J.; Malloy, Mary J.; Kane, John P.
July 2002
Journal of Clinical Investigation;7/1/2002, Vol. 110 Issue 1, p109
Academic Journal
journal article
Bile acid synthesis plays a critical role in the maintenance of mammalian cholesterol homeostasis. The CYP7A1 gene encodes the enzyme cholesterol 7alpha-hydroxylase, which catalyzes the initial step in cholesterol catabolism and bile acid synthesis. We report here a new metabolic disorder presenting with hyperlipidemia caused by a homozygous deletion mutation in CYP7A1. The mutation leads to a frameshift (L413fsX414) that results in loss of the active site and enzyme function. High levels of LDL cholesterol were seen in three homozygous subjects. Analysis of a liver biopsy and stool from one of these subjects revealed double the normal hepatic cholesterol content, a markedly deficient rate of bile acid excretion, and evidence for upregulation of the alternative bile acid pathway. Two male subjects studied had hypertriglyceridemia and premature gallstone disease, and their LDL cholesterol levels were noticeably resistant to 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. One subject also had premature coronary and peripheral vascular disease. Study of the kindred, which is of English and Celtic background, revealed that individuals heterozygous for the mutation are also hyperlipidemic, indicating that this is a codominant disorder.


Related Articles

  • Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1. Eden, Emily R.; Patel, Dilipkumar D.; Xi-Ming Sun; Burden, Jemima J.; Themis, Michael; Edwards, Matthew; Lee, Philip; Neuwirth, Clare; Naoumova, Rossitza P.; Soutar, Anne K.; Sun, Xi-Ming // Journal of Clinical Investigation;12/1/2002, Vol. 110 Issue 11, p1695 

    Familial hypercholesterolemia is an autosomal dominant disorder with a gene-dosage effect that is usually caused by mutations in the LDL receptor gene that disrupt normal clearance of LDL. In the homozygous form, it results in a distinctive clinical phenotype, characterized by inherited...

  • Early and severe neurological features in a Wilson disease patient compound heterozygous for two frameshift mutations. Angius, A.; Dessi, V.; Lovicu, M.; De Virgiliis, S.; Pirastu, M.; Cao, A.; Antonio, C. // European Journal of Pediatrics;1998, Vol. 157 Issue 2, p128 

    Unlabelled: We describe a patient with Wilson disease who presented at 11 years of age with neurological symptoms and subsequent rapid progression of neurological impairment but absent hepatic manifestations. Molecular analysis showed compound heterozygosity for two frameshift...


    Consanguineous unions are a deeply rooted social practice among traditional societies. Despite their presumed social advantages, they can result in several health conditions. The aim of this study was: i) to compare consanguinity levels between Tunisian patients affected with autosomal recessive...

  • Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. Jones, Christopher; Garuti, Rita; Michaely, Peter; Wei-Ping Li; Maeda, Nobuyo; Cohen, Jonathan C.; Herz, Joachim; Hobbs, Helen H.; Li, Wei-Ping // Journal of Clinical Investigation;Jan2007, Vol. 117 Issue 1, p165 

    Genetic defects in LDL clearance result in severe hypercholesterolemia and premature atherosclerosis. Mutations in the LDL receptor (LDLR) cause familial hypercholesterolemia (FH), the most severe form of genetic hypercholesterolemia. A phenocopy of FH, autosomal recessive hypercholesterolemia...

  • A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Højlund, Kurt; Hansen, Torben; Lajer, Maria; Henriksen, Jan Erik; Levin, Klaus; Lindholm, Jörgen; Pedersen, Oluf; Beck-Nielsen, Henning; Højlund, Kurt; Lindholm, Jörgen // Diabetes;Jun2004, Vol. 53 Issue 6, p1592 

    Recently, various subtypes of familial hyperinsulinemic hypoglycemia with an autosomal-dominant inheritance have been etiologically characterized. In the present study, we have delineated the genetics and metabolic phenotype of a novel form of hypoglycemia in a large pedigree with an apparent...

  • Human CYP7A1 deficiency: progress and enigmas. Beigneux, Anne; Hofmann, Alan F.; Young, Stephen G. // Journal of Clinical Investigation;7/1/2002, Vol. 110 Issue 1, p29 

    Discusses the progress and enigmas in human CYP7A1 deficiency. Association between low levels of bile acids synthesis, as in CYP7A1 with hypertriglyceridemia; Qualitative and quantitative effects on bile acids; Differences in CYP7A1-deficient mice and humans.

  • Type II benign osteopetrosis (Albers-Schönberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations. Letizia, C.; Taranta, A.; Migliaccio, S.; Caliumi, C.; Diacinti, D.; Delfini, E.; D'Erasmo, E.; Iacobini, M.; Roggini, M.; Albagha, O. M. E.; Ralston, S. H.; Teti, A. // Calcified Tissue International;Jan2004, Vol. 74 Issue 1, p42 

    A 16-year-old male patient with type II autosomal dominant benign osteopetrosis (ADO) was genotyped and found to harbor a novel mutation in exon 25 of the gene encoding for the osteoclast-specific chloride channel, CLCN7, inherited from the father, who was asymptomatic. The patient had normal...

  • Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. MacArthur, Jennifer M.; Bishop, Joseph R.; Stanford, Kristin I.; Lianchun Wang; Bensadoun, André; Witztum, Joseph L.; Esko, Jeffrey D.; Wang, Lianchun; Bensadoun, André // Journal of Clinical Investigation;Jan2007, Vol. 117 Issue 1, p153 

    We examined the role of hepatic heparan sulfate in triglyceride-rich lipoprotein metabolism by inactivating the biosynthetic gene GlcNAc N-deacetylase/N-sulfotransferase 1 (Ndst1) in hepatocytes using the Cre-loxP system, which resulted in an approximately 50% reduction in sulfation of liver...

  • Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. Li-Hawkins, Jia; Gåfvels, Mats; Olin, Maria; Lund, Erik G; Andersson, Ulla; Schuster, Gertrud; Björkhem, Ingemar; Russell, David W; Eggertsen, Gosta // Journal of Clinical Investigation;10/1/2002, Vol. 110 Issue 7, p1191 

    Cholesterol is converted into dozens of primary and secondary bile acids through pathways subject to negative feedback regulation mediated by the nuclear receptor farnesoid X receptor (FXR) and other effectors. Disruption of the sterol 12alpha-hydroxylase gene (Cyp8b1) in mice prevents the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics